Literature DB >> 31382038

Gram-Negative Pneumonia Augments Non-Small Cell Lung Cancer Metastasis through Host Toll-like Receptor 4 Activation.

Stephen D Gowing1, Simon C Chow1, Jonathan J Cools-Lartigue1, Crystal B Chen1, Sara Najmeh1, Marnie Goodwin-Wilson1, Henry Y Jiang1, France Bourdeau1, Annie Beauchamp2, Isabelle Angers2, Betty Giannias1, Jonathan D Spicer1, Simon Rousseau3, Salman T Qureshi2, Lorenzo E Ferri4.   

Abstract

INTRODUCTION: Surgery is essential for cure of early-stage non-small cell lung cancer (NSCLC). Rates of postoperative bacterial pneumonias, however, remain high, and clinical data suggests that post-operative infectious complications confer an increased risk for metastasis. Toll-like receptors (TLRs) mediate the inflammatory response to infection by recognizing evolutionarily conserved bacterial structures at the surface of numerous pulmonary cell types; yet, little is known about how host TLR activation influences NSCLC metastasis. TLR4 recognizes gram-negative bacterium lipopolysaccharide activating the innate immune system.
METHODS: C57BL/6 and TLR4 knockout murine airways were inoculated with Escherichia coli or lipopolysaccharide. Hepatic metastasis assays and intravital microscopy were performed. Bronchoepithelial conditioned media was generated through coincubation of bronchoepithelial cells with TLR4 activating Escherichia coli or lipopolysaccharide. Subsequently, H59 NSCLC were stimulated with conditioned media and subject to various adhesion assays.
RESULTS: We demonstrate that gram-negative Escherichia coli pneumonia augments the formation of murine H59 NSCLC liver metastases in C57BL/6 mice through TLR4 activation. Additionally, infected C57BL/6 mice demonstrate increased H59 NSCLC in vivo hepatic sinusoidal adhesion compared with negative controls, a response that is significantly diminished in TLR4 knockout mice. Similarly, intratracheal injection of purified TLR4 activating lipopolysaccharide increases in vivo adhesion of H59 cells to murine hepatic sinusoids. Furthermore, H59 cells incubated with bronchoepithelial conditioned medium show increased cell adhesion to in vitro extracellular matrix proteins and in vivo hepatic sinusoids through a mechanism dependent on bronchoepithelial TLR4 activation and interleukin-6 secretion.
CONCLUSION: TLR4 is a viable therapeutic target for NSCLC metastasis augmented by gram-negative pneumonia.
Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer metastasis; Non–small cell lung cancer; Pneumonia; Toll-like receptors

Year:  2019        PMID: 31382038     DOI: 10.1016/j.jtho.2019.07.023

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  5 in total

1.  Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis.

Authors:  Veena Sangwan; Luai Al-Marzouki; Sanjima Pal; Vivian Stavrakos; Malak Alzahrani; Dorothy Antonatos; Yehonatan Nevo; Sophie Camilleri-Broët; Roni Rayes; France Bourdeau; Betty Giannias; Nicholas Bertos; Swneke Bailey; Simon Rousseau; Jonathan Cools-Lartigue; Jonathan D Spicer; Lorenzo Ferri
Journal:  Clin Exp Metastasis       Date:  2021-11-12       Impact factor: 5.150

2.  Etiology of Community-Acquired Pneumonia Requiring Hospital Admission in Adults with and Without Cancers: A Single-Center Retrospective Study in China.

Authors:  Xinxin Wang; Haihua Zhang; Tao Zhang; Lei Pan; Ke Dong; Ming Yang; Ruina Ma; Yujuan Li
Journal:  Infect Drug Resist       Date:  2020-06-08       Impact factor: 4.003

3.  Investigation and Functional Enrichment Analysis of the Human Host Interaction Network with Common Gram-Negative Respiratory Pathogens Predicts Possible Association with Lung Adenocarcinoma.

Authors:  Lydia-Eirini Giannakou; Athanasios-Stefanos Giannopoulos; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Erasmia Rouka; Sotirios G Zarogiannis
Journal:  Pathophysiology       Date:  2021-01-02

4.  Alterations of lung microbiota in patients with non-small cell lung cancer.

Authors:  Wen Zeng; ChengZhu Zhao; Mengge Yu; Hailong Chen; Yiyun Pan; Yuhuan Wang; Hejing Bao; Hao Ma; Shudong Ma
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

5.  The airway microbiota of non-small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation.

Authors:  Dan Hui Huang; Jing He; Xiao Fang Su; Ya Na Wen; Shu Jia Zhang; Lai Yu Liu; Haijin Zhao; Cui Pin Ye; Jian Hua Wu; Shaoxi Cai; Hangming Dong
Journal:  Thorac Cancer       Date:  2022-02-10       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.